However, given the link between the ω-3 PUFA sEH product; 19,20-DHDP, and diabetic retinopathy (Hu et al., 2017a), infants with higher sEH expression are less likely to benefit from the supplementation with ω-3 PUFAs. This evidence concerns the gene EPHX2 and diabetic retinopathy.